Jove
Visualize
Contact Us

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2024 edition of the Rourke Baby Record.

Canadian family physician Medecin de famille canadien·2025
Same author

Édition 2024 du Relevé postnatal Rourke.

Canadian family physician Medecin de famille canadien·2025
Same author

Powassan virus encephalitis in a 9-year-old.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2024
Same author

Virtual family-centered rounds: a quality improvement initiative to adapt inpatient care during COVID-19 using a human-centred participatory design approach.

BMC pediatrics·2023
Same author

Procedural skill needs for Canadian paediatricians: A national profile.

Paediatrics & child health·2023
Same author

Canadian family physician Medecin de famille canadien·2022
Same journal

A call for equity-informed pediatric palliative care in Canada.

Paediatrics & child health·2026
Same journal

Streamlining Kawasaki disease care: a quality improvement initiative to safely reduce length of stay.

Paediatrics & child health·2026
Same journal

La prise en charge de la dilatation des voies urinaires en période anténatale : un point de pratique clinique pour les prestataires de soins néonatals.

Paediatrics & child health·2026
Same journal

Proteinuria and gall bladder wall thickness as predictive indicators for dengue severity in pediatric patients.

Paediatrics & child health·2026
Same journal

Medical assistance in dying in pediatrics: a retrospective case study of clinical interactions and implications for team training.

Paediatrics & child health·2026
Same journal

Bill 79 and the search for truth for missing or deceased Indigenous children: Implications for paediatricians and the duty of memory.

Paediatrics & child health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing functional constipation in children.

Anne Rowan-Legg,

    Paediatrics & Child Health
    |December 4, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric constipation, a common issue, requires prompt management focusing on soft, painless stools. Effective treatments include education, behavioral changes, stool softeners like polyethylene glycol, and dietary adjustments.

    Keywords:
    ConstipationEncopresisLaxativePaediatric

    Related Experiment Videos

    Area of Science:

    • Pediatrics
    • Gastroenterology

    Background:

    • Constipation is a prevalent childhood issue with significant somatic and psychological impacts.
    • The causes are typically multifactorial, rarely stemming from organic pathology.

    Purpose of the Study:

    • To outline the essential components of effective pediatric constipation management.
    • To highlight safe and well-tolerated long-term treatment options.

    Main Methods:

    • Management involves fecal disimpaction if necessary, followed by education and behavioral modification.
    • Daily maintenance with stool softeners, such as polyethylene glycol, and dietary changes are key.
    • Investigations are infrequently required.

    Main Results:

    • Prompt and thorough management leads to soft, painless stools and prevents fecal reaccumulation.
    • Polyethylene glycol demonstrates safety, efficacy, and good tolerability for long-term use.
    • Regular follow-up is crucial for successful outcomes.

    Conclusions:

    • Comprehensive management strategies are vital for pediatric constipation.
    • Polyethylene glycol is a recommended long-term treatment.
    • Referral to a gastroenterologist is indicated for refractory cases or suspected organic pathology.